Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
146.77B
Market cap146.77B
Price-Earnings ratio
54.02
Price-Earnings ratio54.02
Dividend yield
Dividend yield
Average volume
9.59M
Average volume9.59M
High today
$101.82
High today$101.82
Low today
$99.00
Low today$99.00
Open price
$100.90
Open price$100.90
Volume
7.98M
Volume7.98M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

Boston Scientific(BSX) stock is priced at $99.30, giving the company a market capitalization of 146.77B. It carries a P/E multiple of 54.02.

As of 2025-12-03, Boston Scientific(BSX) stock has fluctuated between $99.00 and $101.82. The current price stands at $99.30, placing the stock +0.3% above today's low and -2.5% off the high.

Boston Scientific(BSX) shares are trading with a volume of 7.98M, against a daily average of 9.59M.

In the last year, Boston Scientific(BSX) shares hit a 52-week high of $109.50 and a 52-week low of $85.98.

In the last year, Boston Scientific(BSX) shares hit a 52-week high of $109.50 and a 52-week low of $85.98.

BSX News

Nasdaq 22h
M&A Strategy Strengthens Boston Scientific's Growth Prospects

Over the past several years, Boston Scientific BSX has pursued a series of acquisitions in support of its growth strategy, both strengthening its core businesse...

M&A Strategy Strengthens Boston Scientific's Growth Prospects
Simply Wall St 22h
Boston Scientific: Evaluating Valuation as Growth Prospects Draw Fresh Investor Interest

Boston Scientific (BSX) is drawing attention after an investment manager highlighted strong demand for its less-invasive cardiac and chronic-pain solutions. The...

Boston Scientific: Evaluating Valuation as Growth Prospects Draw Fresh Investor Interest
Nasdaq 2d
Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

Peter Lynch Detailed Fundamental Analysis - BSX

Analyst ratings

97%

of 36 ratings
Buy
97.2%
Hold
2.8%
Sell
0%

More BSX News

Simply Wall St 6d
What Boston Scientific's Raised Revenue Outlook Means For Shareholders

Earlier this week, Boston Scientific reported quarterly revenues of US$5.07 billion, reflecting over 20% year-on-year growth and surpassing analysts' expectatio...

What Boston Scientific's Raised Revenue Outlook Means For Shareholders

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.